Simulations Plus (SLP)

Common Shares
Sell: $42.9|Buy: $60|Change: 0.57 (1.15%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Company profile

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.

Address

42505 Tenth Street West
Lancaster
CA
USA
93534-7059


Telephone

+1 661 723-7723


Sector 

Healthcare


Forecast key dates

NameKey Date
Simulations Plus Inc Second Quarter Earnings Conference Call for 20252025-04-03T17:00:00
Simulations Plus Inc Second Quarter Earnings Results for 20252025-04-03T00:00:00
Simulations Plus Inc Annual General Meeting for 20242025-02-07T14:00:00
Simulations Plus Inc First Quarter Earnings Conference Call for 20252025-01-03T17:00:00
Simulations Plus Inc First Quarter Earnings Results for 20252025-01-03T00:00:00
Simulations Plus Inc Fourth Quarter Earnings Conference Call for 20242024-10-25T17:00:00
Simulations Plus Inc Fourth Quarter Earnings Results for 20242024-10-25T00:00:00
Simulations Plus Inc Annual Report for 20242024-10-25T00:00:00
Simulations Plus Inc Third Quarter Earnings Conference Call for 20242024-07-05T17:00:00
Simulations Plus Inc Third Quarter Earnings Results for 20242024-07-05T00:00:00
PAGE 20242024-06-24T00:00:00
APS Physiologically Based Biopharmaceutics Modelling Conference 20242024-06-20T00:00:00
Discovery Toxicology2024-06-12T00:00:00
Complimentary Introduction to GPX™ Workshop for New-to-GastroPlus® Users2024-06-11T09:00:00
DISSO America 20242024-06-11T00:00:00
In Silico PBPK / PBBM Modeling and Simulation for Industry and Academia Workshop at the 2024 CSPS Annual Symposium2024-06-10T09:00:00
2024 CSPS Annual Symposium2024-06-10T00:00:00
MIDD+ San Francisco 20242024-06-06T00:00:00
Complimentary Introduction to GPX™ Workshop for Current GastroPlus® v9 Users2024-06-04T08:00:00
GMP Workshop: Chasing Optimum First-in-Human Dose2024-05-31T09:00:00
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference2024-05-29T00:00:00
SLP Office Hours: MonolixSuite™2024-05-22T09:00:00
AASLD Drug Induced Liver Injury Meeting2024-05-17T00:00:00
Demystifying GPX™ Installation: Expert Insights and Practical Tips2024-05-16T08:00:00
GPX™: The Next Level PBPK Platform2024-05-15T08:00:00
Complimentary Introduction to GPX™ Workshop for New-to-GastroPlus® Users2024-05-11T09:00:00
MIDD+ Boston 20242024-05-06T00:00:00
ARVO 20242024-05-05T00:00:00

Previous key dates

NameKey Date
GMP Workshop: Chasing Optimum First-in-Human Dose2024-05-31T09:00:00
Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference2024-05-29T00:00:00
SLP Office Hours: MonolixSuite™2024-05-22T09:00:00
AASLD Drug Induced Liver Injury Meeting2024-05-17T00:00:00
Demystifying GPX™ Installation: Expert Insights and Practical Tips2024-05-16T08:00:00
GPX™: The Next Level PBPK Platform2024-05-15T08:00:00
Complimentary Introduction to GPX™ Workshop for New-to-GastroPlus® Users2024-05-11T09:00:00
MIDD+ Boston 20242024-05-06T00:00:00
ARVO 20242024-05-05T00:00:00
Simulations Plus Inc Second Quarter Earnings Conference Call for 20242024-04-03T17:00:00
Simulations Plus Inc Second Quarter Earnings Result for 20242024-04-03T00:00:00
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum2024-03-20T16:30:00
Simulations Plus to Participate in Upcoming Healthcare Conferences2024-02-13T11:20:00
Investor meetings2024-02-13T00:00:00
Simulations Plus Inc Annual General Meeting for 20232024-02-08T14:00:00
Simulations Plus Inc First Quarter Earnings Conference Call for 20242024-01-03T17:00:00
Simulations Plus Inc First Quarter Earnings Result for 20242024-01-03T00:00:00
Simulations Plus Inc Annual Report for 20232023-10-27T00:00:00
Simulations Plus Inc Fourth Quarter Earnings Conference Call for 20232023-10-25T17:00:00
Simulations Plus Inc Fourth Quarter Earnings Result for 20232023-10-25T00:00:00
Simulations Plus Inc Third Quarter Earnings Conference Call for 20232023-07-06T17:00:00
Simulations Plus Inc Third Quarter Earnings Result for 20232023-07-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.